首页> 外文期刊>RSC Advances >Dual encapsulation of hydrophobic and hydrophilic drugs in PLGA nanoparticles by a single-step method: drug delivery and cytotoxicity assays
【24h】

Dual encapsulation of hydrophobic and hydrophilic drugs in PLGA nanoparticles by a single-step method: drug delivery and cytotoxicity assays

机译:单步法通过单步方法进行PLGA纳米粒子中疏水性和亲水药物的双封装:药物递送和细胞毒性测定

获取原文
           

摘要

Dual drug encapsulation in biodegradable nanoparticles is always challenging and often requires strenuous optimization of the synthesis–encapsulation processes. This becomes even more difficult when the simultaneous encapsulation of molecules of different polarity is sought. Here we present a modified emulsification–evaporation process to produce polymeric nanoparticles (NPs) made of the biocompatible and biodegradable polymer poly(lactic- co -glycolic acid) (PLGA) and co-encapsulating simultaneously two different drugs, the hydrophobic dexamethasone (DX) and the hydrophilic diclofenac sodium (DS). Three independent processing parameters were systematically modified to promote the incorporation of the different-polarity drugs into PLGA and to control the particle size under 150 nm. The careful selection of the appropriate solvents (ethyl acetate and methanol) was a key requirement for the successful encapsulation of DX and DS. DS and DX release kinetics as well as cytotoxicity assays underlined the therapeutic potential of the dual encapsulation strategy.
机译:可生物降解的纳米颗粒中的双药物包封始终挑战,并且通常需要剧烈优化合成封装过程。当寻求同时封装不同极性的分子时,这变得更加困难。在这里,我们提出了一种改性的乳化蒸发方法,用于产生由生物相容性和可生物降解的聚合物聚(乳酸糖酸)(PLGA)制成的聚合物纳米颗粒(NPS),并同时共封装两种不同的药物,疏水性地塞米松(DX)和亲水二氯芬太钠(DS)。系统地修饰了三个独立的处理参数以促进不同极性药物的掺入PLGA并控制150nm以下的粒度。仔细选择适当的溶剂(乙酸乙酯和甲醇)是成功包封DX和DS的关键要求。 DS和DX释放动力学以及细胞毒性测定强调了双封装策略的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号